NXSCF
Price:
$0.001
Market Cap:
$30.03M
Next Science Limited operates as a medical technology firm, dedicated to the research, development, and commercialization of innovative solutions aimed at mitigating the detrimental effects of biofilms on human health. The company serves markets in both the United States and Australia, building its product portfolio on its proprietary Xbio Technology platform. Among its key offerings are: SURGX: An antimicrobial gel employed for managing surgical infections. BACTISURE: A specialized wound lavage designed to eliminate biofilm. BlastX: An antimicrobial wound gel that not only eradicates bacteria within the gel but also wards off recolonization, all while maintaining an optimal moist healing en...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-01-08
Stock Exchange
OTC
Ticker
NXSCF
According to Next Science Limited’s latest financial reports and current stock price. The company's current ROE is -491.26%. This represents a change of -1252.40% compared to the average of 42.63% of the last 4 quarters.
The mean historical ROE of Next Science Limited over the last ten years is -124.10%. The current -491.26% ROE has changed 295.85% with respect to the historical average. Over the past ten years (40 quarters), NXSCF's ROE was at its highest in in the June 2023 quarter at 49.07%. The ROE was at its lowest in in the December 2018 quarter at -1024.14%.
Average
-124.10%
Median
-87.11%
Minimum
-307.51%
Maximum
-1.35%
Discovering the peaks and valleys of Next Science Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.94%
Maximum Annual ROE = -1.35%
Minimum Annual Increase = -99.26%
Minimum Annual ROE = -307.51%
| Year | ROE | Change |
|---|---|---|
| 2024 | -307.51% | 60.84% |
| 2023 | -191.19% | 23.83% |
| 2022 | -154.40% | 77.26% |
| 2021 | -87.11% | 37.45% |
| 2020 | -63.37% | -15.47% |
| 2019 | -74.97% | 37.24% |
| 2018 | -54.63% | 3.94% |
| 2017 | -1.35% | -99.26% |
The current ROE of Next Science Limited (NXSCF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-217.70%
5-year avg
-160.72%
10-year avg
-124.10%
Next Science Limited’s ROE is greater than Ecofibre Limited (-77.39%), less than Fluent Corp. (128.75%), less than WOWI, Inc. (157.95%), greater than Nova Eye Medical Limited (-40.41%), greater than Charlotte's Web Holdings, Inc. (-2065.45%), less than High Sierra Technologies, Inc. (41.52%), less than Provectus Biopharmaceuticals, Inc. (89.65%), greater than MediPharm Labs Corp. (-23.55%), greater than Alternate Health Corp. (-279.24%), less than iAnthus Capital Holdings, Inc. (61.62%),
| Company | ROE | Market cap |
|---|---|---|
| -77.39% | $378.87K | |
| 128.75% | $10.77M | |
| 157.95% | $6.76K | |
| -40.41% | $4.08M | |
| -2065.45% | $63.46M | |
| 41.52% | $29.35M | |
| 89.65% | $25.64M | |
| -23.55% | $21.46M | |
| -279.24% | $7.79K | |
| 61.62% | $34.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Next Science Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Next Science Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Next Science Limited's ROE?
How is the ROE calculated for Next Science Limited (NXSCF)?
What is the highest ROE for Next Science Limited (NXSCF)?
What is the 3-year average ROE for Next Science Limited (NXSCF)?
What is the 5-year average ROE for Next Science Limited (NXSCF)?
How does the current ROE for Next Science Limited (NXSCF) compare to its historical average?